Drug Profile
BI 671800
Alternative Names: BI-671800; BI-671800 EDLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Seasonal allergic rhinitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma(In volunteers) in United Kingdom (PO, Granules)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma(In volunteers) in United Kingdom (PO, Liquid)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma(In volunteers) in United Kingdom (PO, Tablet)